SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-12 Cr | ₹-1.09 Cr | ₹9.84 Cr | ₹-0.48 Cr | ₹-0.18 Cr |
What is the latest Cash Flow from Financing Activities ratio of SHREE GANESH REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-12 Cr |
| Mar2025 | ₹-1.09 Cr |
| Mar2024 | ₹9.84 Cr |
| Mar2020 | ₹-0.48 Cr |
| Mar2019 | ₹-0.18 Cr |
How is Cash Flow from Financing Activities of SHREE GANESH REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-12 Cr | Negative | |
| Mar2025 | ₹-1.09 Cr | Negative | |
| Mar2024 | ₹9.84 Cr | Positive | |
| Mar2020 | ₹-0.48 Cr | Negative | |
| Mar2019 | ₹-0.18 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹854.5 Cr | -5.5% | 1.1% | 28.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.2% | -5.1% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.8% | -3.2% | 51.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.7% | -7.7% | 29.9% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0.6% | -3.8% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 2.9% | 4.6% | 0.4% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -5.5% |
1.1% |
28.8% |
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses